Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Clovis Oncology Inc (CLVS)

Clovis Oncology Inc (CLVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clovis Oncology Inc 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 USA

P: 303-625-5000 F: 303-245-0360

Description:

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.

Key Statistics

Overview:

Market Capitalization, $K 552,975
Shares Outstanding, K 118,410
Annual Sales, $ 164,520 K
Annual Net Income, $ -369,210 K
Last Quarter Sales, $ 36,820 K
Last Quarter Net Income, $ -66,450 K
60-Month Beta 1.73
% of Insider Shareholders 5.40%
% of Institutional Shareholders 46.66%
Float, K 112,016
% Float 94.60%

Growth:

1-Year Return -18.00%
3-Year Return -84.10%
5-Year Return -87.05%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 55.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -2.88
EPS Growth vs. Prev Qtr 4.69%
EPS Growth vs. Prev Year 45.05%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CLVS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -4.85
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -48.81%
Profit Margin % -224.42
Net Margin % N/A
Debt/Equity N/A
Price/Sales 3.32
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.75
Interest Coverage -11.12
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar